China SXT Pharmaceuticals, Inc. (SXTC) › Total LiabilitiesChina SXT Pharmaceuticals, Inc. (SXTC) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2018: $4.37M2019: $6.36M2020: $12.30M2021: $18.59M2022: $17.12M2023: $14.86M2024: $9.20M2025: $6.22M$6.22M2018Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$6.22M-32.3%2024$9.20M-38.1%2023$14.86M-13.2%2022$17.12M-7.9%2021$18.59M+51.1%2020$12.30M+93.3%2019$6.36M+45.5%2018$4.37M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share